Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 2664

1.

[Challenges for Urologists in the Care of Patients with Lynch Syndrome: Example of A Patient with Muir-Torre Syndrome, A Subtype of Lynch Syndrome].

Löhmann C, Kächele V, Martinschek A, Sparwasser C.

Aktuelle Urol. 2015 Oct 28. [Epub ahead of print] German.

PMID:
26509248
2.

[Clinicopathological screening of Lynch syndrome: a report of 2 cases and literature review].

Si JW, Wang L, Ba XJ, Zhang X, Dong Y, Zhang JX, Li WT, Li T.

Beijing Da Xue Xue Bao. 2015 Oct 18;47(5):858-64. Review. Chinese.

3.

Initial Results of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer and Lynch Syndrome.

Howarth DR, Lum SS, Esquivel P, Garberoglio CA, Senthil M, Solomon NL.

Am Surg. 2015 Oct;81(10):941-4.

PMID:
26463285
4.

Lynch Syndrome Patients with Limited Family History Identified in a Laboratory Setting: A Descriptive Study.

Landon M, Saam J, Brown KL, Moyes K, Evans B, Wenstrup R.

Oncology. 2015;89(4):221-6. doi: 10.1159/000430097. Epub 2015 Jun 6.

5.

Patients Tested at a Laboratory for Hereditary Cancer Syndromes Show an Overlap for Multiple Syndromes in Their Personal and Familial Cancer Histories.

Saam J, Arnell C, Theisen A, Moyes K, Marino I, Roundy KM, Wenstrup RJ.

Oncology. 2015;89(5):288-93. doi: 10.1159/000437307. Epub 2015 Aug 28.

6.

The role of immunohistochemistry in the Muir-Torre Syndrome.

Oliveira CM, Campos JG, Maia MR, Lobo LE, Valle FF.

An Bras Dermatol. 2015 May-Jun;90(3 Suppl 1):168-70. doi: 10.1590/abd1806-4841.20153406.

7.

Target gene mutational pattern in Lynch syndrome colorectal carcinomas according to tumour location and germline mutation.

Pinheiro M, Pinto C, Peixoto A, Veiga I, Lopes P, Henrique R, Baldaia H, Carneiro F, Seruca R, Tomlinson I, Kovac M, Heinimann K, Teixeira MR.

Br J Cancer. 2015 Aug 11;113(4):686-92. doi: 10.1038/bjc.2015.281. Epub 2015 Aug 6.

PMID:
26247575
8.

A case of early onset rectal cancer of Lynch syndrome with a novel deleterious PMS2 mutation.

Nomura S, Fujimoto Y, Yamamoto N, Sato Y, Ashihara Y, Kita M, Yamaguchi J, Ishikawa Y, Ueno M, Arai M.

Jpn J Clin Oncol. 2015 Oct;45(10):987-92. doi: 10.1093/jjco/hyv108. Epub 2015 Aug 1.

PMID:
26232782
9.

Next Generation Multigene Panel Testing: The Next Step for Identification of Hereditary Colorectal Cancer Syndromes?

Ballester V, Boardman L.

Gastroenterology. 2015 Sep;149(3):526-8. doi: 10.1053/j.gastro.2015.07.025. Epub 2015 Jul 27. No abstract available.

PMID:
26226575
10.

DNA Mismatch Repair Status Predicts Need for Future Colorectal Surgery for Metachronous Neoplasms in Young Individuals Undergoing Colorectal Cancer Resection.

Aronson M, Holter S, Semotiuk K, Winter L, Pollett A, Gallinger S, Cohen Z, Gryfe R.

Dis Colon Rectum. 2015 Jul;58(7):645-52. doi: 10.1097/DCR.0000000000000391.

PMID:
26200678
11.

A novel deletion in the splice donor site of MLH1 exon 6 in a Japanese colon cancer patient with Lynch syndrome.

Yamaguchi J, Sato Y, Kita M, Nomura S, Yamamoto N, Kato Y, Ishikawa Y, Arai M.

Jpn J Clin Oncol. 2015 Oct;45(10):993-7. doi: 10.1093/jjco/hyv103. Epub 2015 Jul 16.

PMID:
26185136
12.

Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.

Dashti SG, Chau R, Ouakrim DA, Buchanan DD, Clendenning M, Young JP, Winship IM, Arnold J, Ahnen DJ, Haile RW, Casey G, Gallinger S, Thibodeau SN, Lindor NM, Le Marchand L, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK.

JAMA. 2015 Jul 7;314(1):61-71. doi: 10.1001/jama.2015.6789.

13.

Segregation of a novel MLH1 mutation in an Iranian Lynch syndrome family.

Ghafouri-Fard S, Fardaei M, Lankarani KB, Miryounesi M.

Gene. 2015 Oct 10;570(2):304-5. doi: 10.1016/j.gene.2015.07.005. Epub 2015 Jul 3.

PMID:
26149658
14.

Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.

Bodo S, Colas C, Buhard O, Collura A, Tinat J, Lavoine N, Guilloux A, Chalastanis A, Lafitte P, Coulet F, Buisine MP, Ilencikova D, Ruiz-Ponte C, Kinzel M, Grandjouan S, Brems H, Lejeune S, Blanché H, Wang Q, Caron O, Cabaret O, Svrcek M, Vidaud D, Parfait B, Verloes A, Knappe UJ, Soubrier F, Mortemousque I, Leis A, Auclair-Perrossier J, Frébourg T, Fléjou JF, Entz-Werle N, Leclerc J, Malka D, Cohen-Haguenauer O, Goldberg Y, Gerdes AM, Fedhila F, Mathieu-Dramard M, Hamelin R, Wafaa B, Gauthier-Villars M, Bourdeaut F, Sheridan E, Vasen H, Brugières L, Wimmer K, Muleris M, Duval A; European Consortium “Care for CMMRD”.

Gastroenterology. 2015 Oct;149(4):1017-29.e3. doi: 10.1053/j.gastro.2015.06.013. Epub 2015 Jun 25.

PMID:
26116798
15.

Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.

Ait Ouakrim D, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B, Macrae FA, Ahnen DJ, Casey G, Gallinger S, Haile RW, Le Marchand L, Thibodeau SN, Lindor NM, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK.

J Natl Cancer Inst. 2015 Jun 24;107(9). pii: djv170. doi: 10.1093/jnci/djv170. Print 2015 Sep.

PMID:
26109217
16.

Heterogenous MSH6 loss is a result of microsatellite instability within MSH6 and occurs in sporadic and hereditary colorectal and endometrial carcinomas.

Graham RP, Kerr SE, Butz ML, Thibodeau SN, Halling KC, Smyrk TC, Dina MA, Waugh VM, Rumilla KM.

Am J Surg Pathol. 2015 Oct;39(10):1370-6. doi: 10.1097/PAS.0000000000000459.

PMID:
26099011
17.

Advances in the study of Lynch syndrome in China.

Lu JY, Sheng JQ.

World J Gastroenterol. 2015 Jun 14;21(22):6861-71. doi: 10.3748/wjg.v21.i22.6861. Review.

18.

Lynch syndrome and cervical cancer.

Antill YC, Dowty JG, Win AK, Thompson T, Walsh MD, Cummings MC, Gallinger S, Lindor NM, Le Marchand L, Hopper JL, Newcomb PA, Haile RW, Church J, Tucker KM, Buchanan DD, Young JP, Winship IM, Jenkins MA.

Int J Cancer. 2015 Dec 1;137(11):2757-61. doi: 10.1002/ijc.29641. Epub 2015 Jul 14.

PMID:
26077226
19.

Correlation between Density of CD8+ T-cell Infiltrate in Microsatellite Unstable Colorectal Cancers and Frameshift Mutations: A Rationale for Personalized Immunotherapy.

Maby P, Tougeron D, Hamieh M, Mlecnik B, Kora H, Bindea G, Angell HK, Fredriksen T, Elie N, Fauquembergue E, Drouet A, Leprince J, Benichou J, Mauillon J, Le Pessot F, Sesboüé R, Tuech JJ, Sabourin JC, Michel P, Frébourg T, Galon J, Latouche JB.

Cancer Res. 2015 Sep 1;75(17):3446-55. doi: 10.1158/0008-5472.CAN-14-3051. Epub 2015 Jun 9.

PMID:
26060019
20.

Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.

Seguí N, Mina LB, Lázaro C, Sanz-Pamplona R, Pons T, Navarro M, Bellido F, López-Doriga A, Valdés-Mas R, Pineda M, Guinó E, Vidal A, Soto JL, Caldés T, Durán M, Urioste M, Rueda D, Brunet J, Balbín M, Blay P, Iglesias S, Garré P, Lastra E, Sánchez-Heras AB, Valencia A, Moreno V, Pujana MÁ, Villanueva A, Blanco I, Capellá G, Surrallés J, Puente XS, Valle L.

Gastroenterology. 2015 Sep;149(3):563-6. doi: 10.1053/j.gastro.2015.05.056. Epub 2015 Jun 5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk